Login to Your Account

Deals And M&A NEWS

SAN DIEGO – Glenmark Pharmaceuticals Inc. has struck a deal to license a small-molecule cancer candidate from APC Therapeutics Inc., gaining worldwide development and commercialization rights to a compound based on APC biology.

After a spate of upbeat news, Basilea Pharmaceutica International Ltd. is not slowing down, CEO Ronald Scott said, and the company is “very active in talking to potential partners for our assets at all stages.”

HONG KONG – CSL Ltd. has bought a majority stake in China’s Wuhan Zhong Yuan Ruide Biological Products Co. Ltd. in a $352 million deal that should make the Australian biotech company a market leader.

More Deals And M&A Headlines

Cast Your Vote

Should there be restrictions on the use of gene-editing technology?: